US Stocks
/
Enliven Therapeutics, Inc. Share Price
Enliven Therapeutics, Inc. Share Price

Enliven Therapeutics, Inc. Share Price

NASDAQ: ELVN | Mid Cap
$49.53
-$0.55 (-1.11%) Last updated on 18 Sep, 2026 | 21:48 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Enliven Therapeutics, Inc. Stock Performance

Open
$50.08
Prev. Close
$50.09
Circuit Range
N/A
Day Range
$49.49 - $51.16
Year Range
$14.84 - $61.85
Volume
18,886
Average Traded
$50.30

Enliven Therapeutics, Inc. Share Price Today

As of 18 September 2026, Enliven Therapeutics, Inc.'s share price is $49.53. The stock opened at $50.08, compared to its previous close of $50.09. During today's trading session, Enliven Therapeutics, Inc.'s share price traded between $49.49 and $51.16, with an average price of $50.33. Over the past 52 weeks, the stock has recorded a high of $61.85 and a low of $14.84. In terms of performance, Enliven Therapeutics, Inc.'s share price has risen by 26.58% over the last six months and is up 141.73% on a year-on-year basis.

Enliven Therapeutics, Inc. Share Price Chart

$49.49$51.16
L
Show Current Price
H

Enliven Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$2.81B
PE Ratio (TTM)
-27.07
Dividend Yield
N/A
EPS (TTM)
$-1.83
Revenue (TTM)
N/A
Return On Equity (TTM)
-22.56%
Profit Margin
N/A
Debt to Equity
0.04
Quarterly Earnings Growth YoY
12.99%

Enliven Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025
RevenueN/AN/AN/AN/AN/AN/A
Net Profit-$22.74M-$19.95M-$23.16M-$28.54M-$25.34M-$20.15M
Net Profit MarginN/AN/AN/AN/AN/AN/A
Income ChangeN/A12.26%-16.07%-23.27%11.24%20.47%

Enliven Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars20212022202320242025
RevenueN/AN/AN/AN/AN/A
Net Profit-$51.38M$1.49M-$71.58M-$89.02M-$103.69M
Net Profit MarginN/AN/AN/AN/AN/A
Income ChangeN/A102.90%-4910.75%-24.36%-16.48%

About Enliven Therapeutics, Inc.

Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer. The company's lead product candidates comprise ELVN-001, a small molecule kinase inhibitor which is in Phase 1 clinical trial to treat adults with chronic myeloid leukemia; and ELVN-002, a CNS penetrant and irreversible HER2 inhibitor that is in Phase 1 clinical trial for the treatment of non-small cell lung cancer (NSCLC) and other HER2 driven cancers and solid tumors. The company is headquartered in Boulder, Colorado.

Enliven Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Sep 2026
$57.93
$49.55
-18.08%
Aug 2026
$53.50
$60.48
+10.43%
Jul 2026
$51.27
$54.77
+7.92%
Jun 2026
$38.73
$50.75
+28.14%
May 2026
$40.73
$39.60
-4.00%
Apr 2026
$39.57
$41.26
+5.43%
Mar 2026
$29.48
$39.13
+31.80%
Feb 2026
$26.25
$29.69
+12.00%
Jan 2026
$15.34
$26.51
+72.25%
Dec 2025
$20.78
$15.39
-28.75%
Nov 2025
$22.66
$21.60
-7.85%
Oct 2025
$20.45
$23.44
+14.40%

ELVN Share Price FAQs

What is Enliven Therapeutics, Inc. share price today?

chevron-up
Enliven Therapeutics, Inc. share price today is $49.53 as on September 18, 2026 at 9:48 pm IST.

What is the 52 week high and 52 week low of Enliven Therapeutics, Inc. stock?

chevron-up
The 52 week high of Enliven Therapeutics, Inc. stock is $61.85, while the 52 week low is $14.84 as of 18 Sep '26.

What is ELVN's market capitalisation today?

chevron-up
ELVN market capitalisation is $2.81B as of September 18, 2026, at 9:48 pm IST.

What is ELVN's net income for the last quarter?

chevron-up
ELVN's net income for the last quarter is -0.02B USD.

What is the 5 year returns of ELVN?

chevron-up
The 5 year returns of ELVN is 203.49% as on 18 Sep '26.

What is the high & low stock price of ELVN today?

chevron-up
ELVN stock price hit a high of $51.16 and low of $49.49 as of 18 Sep '26.

Can I buy ELVN shares in India?

chevron-up
Yes. You can buy ELVN in India by opening an international trading account.